Oncobox
Oncobox offers tailored cancer therapy selection for each patient through deep molecular profiling of tumors. Their Oncobox Dx platform analyzes DNA and RNA to evaluate the effectiveness of 170 targeted and immunotherapy drugs, assisting healthcare providers in creating personalized treatment plans. The company's approach has demonstrated significant clinical efficacy, as evidenced by case studies where patients achieved complete remission or prolonged survival. Oncobox leverages system biology and omics technologies, supported by a US patent for its genetic information analysis platform. Their research also explores machine learning for cancer genetic data analysis and predicting drug effectiveness through molecular pathways.
Oncobox
Oncobox offers tailored cancer therapy selection for each patient through deep molecular profiling of tumors. Their Oncobox Dx platform analyzes DNA and RNA to evaluate the effectiveness of 170 targeted and immunotherapy drugs, assisting healthcare providers in creating personalized treatment plans. The company's approach has demonstrated significant clinical efficacy, as evidenced by case studies where patients achieved complete remission or prolonged survival. Oncobox leverages system biology and omics technologies, supported by a US patent for its genetic information analysis platform. Their research also explores machine learning for cancer genetic data analysis and predicting drug effectiveness through molecular pathways.